Home / Inspections / 1215712

FDA Inspection 1215712 — Carter BloodCare at Garland

Carter BloodCare at Garland — FEI 1641736

The FDA completed an inspection of Carter BloodCare at Garland on August 15, 2023 in Garland, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 15, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Garland, TX (United States)

Facility

Other inspections at this facility

  • 1080790 (NAI Wed Feb 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 988835 (NAI Fri Oct 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 901104 (NAI Thu Oct 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 803362 (NAI Thu Oct 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 574970 (NAI Fri Apr 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources